CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- Open-market buys, last 90 days
- $291,587
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$291,587. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-09-06 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option | +106,667 | 106,667 | ||
| 2017-09-06 | KUMAR AMIT Chief Executive Officer | Returned to the company · Employee Stock Option | −213,333 | 0 | ||
| 2017-09-06 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option | +213,333 | 213,333 | ||
| 2017-09-06 | KUMAR AMIT Chief Executive Officer | Returned to the company · Employee Stock Option | −40,000 | 0 | ||
| 2017-09-06 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option | +40,000 | 40,000 | ||
| 2017-09-06 | KUMAR AMIT Chief Executive Officer | Returned to the company · Employee Stock Option | −200,000 | 0 | ||
| 2017-09-06 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option | +200,000 | 200,000 | ||
| 2017-07-06 | Catelani Michael Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2017-06-05 | KUMAR AMIT Director | Purchase | +10,000 | $0.90 | $9K | 124,408 |
| 2017-06-02 | BERMAN ROBERT ANDREW President & CEO | Purchase | +100 | $0.85 | $85 | 51,653 |
| 2017-06-02 | BERMAN ROBERT ANDREW President & CEO | Purchase | +9,900 | $0.88 | $9K | 61,553 |
| 2017-06-02 | KUMAR AMIT Director | Purchase | +500 | $0.86 | $430 | 104,908 |
| 2017-06-02 | KUMAR AMIT Director | Purchase | +1,422 | $0.87 | $1K | 106,330 |
| 2017-06-02 | KUMAR AMIT Director | Purchase | +8,078 | $0.88 | $7K | 114,408 |
| 2017-04-03 | BERMAN ROBERT ANDREW President and CEO | Option exercise | +5,995 | $2.38 | $14K | 51,553 |
| 2017-04-03 | BERMAN ROBERT ANDREW President and CEO | Option exercise · Subscription Right | −5,995 | 0 | ||
| 2017-01-03 | MONAHAN JOHN J Director | Grant or award · Employee Stock Options (Right to Buy) | +12,000 | 12,000 | ||
| 2017-01-03 | Fox Dale Director | Grant or award · Employee Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2017-01-03 | Baskies Arnold M Director | Grant or award · Employee Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2017-01-03 | MONAHAN JOHN J Director | Grant or award · Employee Stock Options (Right to Buy) | +12,000 | 12,000 |
Page 16 of 21 · 404 trades